Phrontline Biopharma
Phrontline Biopharma develops biopharmaceutical products to treat cancer through innovative antibody-drug conjugate technology.
$40M Series A ·
Led by Decheng Capital · Source: ifastdata.com
Total raised: $100M across 2 sourced rounds
All 2 rounds ↓Funding rounds
- Series A · $40M
DDecheng Capital (lead),
OOriza Holdings (lead), JJifeng Capital,
LLapam Capital,
MMed-Fine Capital, SSongqing Capital,
XXiamen C&D Corporation
Source: ifastdata.com - Seed · $60M
LLongpan Investment (lead),
DDecheng Capital,
GGuofang Innovation,
HHankang Capital, JJifeng Capital,
MMed-Fine Capital,
SSamsung Ventures, SSino Biopharmaceutical, SSongqing Capital,
XXiamen C&D Emerging Industry Equity Investment
Source: morningstar.com
Investors
DDecheng Capitallead investor
GGuofang Innovation
HHankang Capital
- JJifeng Capital
LLapam Capital
LLongpan Investmentlead investor
MMed-Fine Capital
OOriza Holdingslead investor
SSamsung Ventures
- SSino Biopharmaceutical
- SSongqing Capital
XXiamen C&D Corporation
XXiamen C&D Emerging Industry Equity Investment
Companies like Phrontline Biopharma
VVelosbioSeries B+ · Aug 2026
AAdcytherixSeries A · Oct 2025
OOna Therapeutics$86.6M Series B+ · Oct 2026
AAdcendo$75M Series B+ · Apr 2026
TTubulis$360M Series B+ · Oct 2025PPanTargPre Seed · Sep 2026
Other companies backed by Decheng Capital
PPolares Medical$50M Series B+ · Mar 2026
YYolTech Therapeutics$45M Series B+ · Sep 2025
VVintaBio$64M · Apr 2023
MMirvie$60M Series B+ · May 2022
AAnHeart Therapeutics$61M Series B+ · Dec 2021
HHaoxinqingSeries B+ · Sep 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/phrontline-biopharma (get a free API key).